webinar register page

Webinar banner
Why Does Someone Develop Pancreatic Cancer?
The implementation of universal genetic testing recommendations for individuals with pancreatic cancer has improved access to genetic testing and diagnosis of hereditary cancer predisposition syndromes. However, inherited pancreatic cancer predisposition syndromes are only a piece of a much larger, complex picture. What risk factors contribute to a person’s risk for pancreatic cancer? Why do some individuals develop pancreatic cancer and others do not? What is genetic testing and how can it benefit individuals and their family members? In this webinar, we break down currently known risk factors for pancreatic cancer, including genetic and environmental factors, and the role of clinical genetic testing in both clinical care and research initiatives.

Oct 28, 2020 07:00 PM in Eastern Time (US and Canada)

Ariel Precision Medicine & National Pancreas Foundation
* Required information
Loading

By registering, I agree to the Privacy Statement and Terms of Service.

Register

Speakers

Celeste Shelton, PhD, CGC
Variant Scientist & Certified Genetic Counselor @Ariel Precision Medicine
Celeste Shelton, PhD, CGC, is a graduate of the M.S. in Genetic Counseling program at the University of Pittsburgh. After graduating with her degree and certification in genetic counseling, she worked as a genetic counselor in gastrointestinal diseases before completing a Ph.D. in Human Genetics, also from the University of Pittsburgh. Her contributions have focused on pancreatic diseases using a comprehensive approach of genetics, statistics, bioinformatics, and qualitative methodologies. In 2019, Dr. Shelton joined Ariel Precision Medicine as a clinical variant scientist, where she continues to study genetic contributions to pancreatic disease. Her primary research interest is the use of genetic and other data to improve mechanistic subclassification and risk prediction for patients with complex disorders, to thereby improve clinical management and facilitate the identification of targeted therapies.
Randall E. Brand, MD
Professor & Gastroenterologist @UPMC
Dr. Brand is a Professor of Medicine at the University of Pittsburgh and a Gastroenterologist at the University of Pittsburgh Medical Center. His clinical focus is on the management of pancreatic cancer, cystic lesions of the pancreas, and other gastrointestinal (GI) cancers. He is the director of the UPMC's GI Tumor Program, leader of the University of Pittsburgh’s Pancreatic Adenocarcinoma Gene-Environment Registry (PAGER), and contributor to the Early Detection Research Network.